The Grey Nuns Community Hospital is an acute care hospital located in the Mill Woods area of south Edmonton, Alberta, Canada. The Grey Nuns Community Hospital provides a full range of services including a 24-hour Emergency Department.

There are 363 beds in Grey Nuns Community Hospital.

During the past decade, Grey Nuns Community Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 9 clinical trials were completed, i.e. on average, 34.6% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grey Nuns Community Hospital" #1 sponsor was "University of Alberta" with 19 trials, followed by "University of Calgary" with 6 trials sponsored, "Daren K. Heyland" with 2 trials sponsored, "GlycoMimetics Incorporated" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grey Nuns Community Hospital" #1 collaborator was "Alberta Health services" with 6 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 5 trials as a collaborator, "Alberta Innovates Health Solutions" with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 2 trials as a collaborator and "Capital Health, Canada" with 2 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Grey Nuns Community Hospital" are "Stroke" (6 trials), "Atrial Fibrillation" (3 trials), "Critical Illness" (3 trials), "Myocardial Infarction" (3 trials) and "Acute Ischemic Stroke" (2 trials). Many other conditions were trialed in "Grey Nuns Community Hospital" in a lesser frequency.

Most popular intervention types in "Grey Nuns Community Hospital" are "Drug" (26 trials), "Other" (13 trials), "Device" (9 trials), "Procedure" (6 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Dabigatran" (2 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.

The vast majority of trials in "Grey Nuns Community Hospital" are 54 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Grey Nuns Community Hospital". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Grey Nuns Community Hospital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Grey Nuns Community Hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 18 trials that are defined as “Not Applicable".